These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 30380840)

  • 1. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
    Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
    Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
    Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
    J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
    Fowble KL; Musah RA
    Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
    Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
    J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.).
    Limsuwanchote S; Wungsintaweekul J; Keawpradub N; Putalun W; Morimoto S; Tanaka H
    Forensic Sci Int; 2014 Nov; 244():70-7. PubMed ID: 25216455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom.
    Le D; Goggin MM; Janis GC
    J Anal Toxicol; 2012; 36(9):616-25. PubMed ID: 23024321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature.
    Heywood J; Smallets S; Paustenbach D
    Food Chem Toxicol; 2024 Oct; 192():114913. PubMed ID: 39134135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
    Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl ester and aromatic ether modification of mitragynine for generation of mitragynine-specific polyclonal antibodies.
    Mustafa RR; Sukor R; Mohd Nor SM; Saari N
    J Immunol Methods; 2022 Aug; 507():113291. PubMed ID: 35640723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of metabolites and potential biomarkers of kratom in urine.
    Basiliere S; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for Kratom alkaloids in fingernail clippings - not only mitragynine.
    Ameline A; Gheddar L; Arbouche N; Blanchot A; Raul JS; Kintz P
    J Pharm Biomed Anal; 2024 Jun; 243():116078. PubMed ID: 38489958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
    Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
    Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers.
    Rhee J; Shin I; Kim J; Lee J; Cho B; Kim J; Park M; Kim E
    J Anal Toxicol; 2024 Jul; 48(6):429-438. PubMed ID: 38780234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
    Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
    Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.